Clinical Trial: ACP-204 in Adults With Alzheimer's Disease Psychosis
Study Status: Completed
Recruit Status: RECRUITING
Condition: Alzheimer's Disease Psychosis
Study Type: INTERVENTIONAL
Official Title: A Master Protocol for Three Independent, Seamlessly Enrolling, Double-blind, Placebo-controlled Efficacy and Safety Studies of ACP-204 in Adults With Alzheimer's Disease Psychosis
Brief Summary:
This is a master protocol for 3 independent, seamlessly enrolling, multicenter, randomized, double-blind, placebo-controlled, parallel-group studies in patients with ADPSubstudy 1 (Phase 2) will evaluate efficacy and dose response of ACP-204 30 and 60 mg vs placebo.This substudy will be initiated first.Substudies 2A and 2B (both: Phase 3) will be confirmatory studies of either both doses (ACP-204 30 and 60 mg, respectively) or a single dose from Part 1 vs placebo.Substudies 2A and 2B will be performed…
Read more